August 28, 2018 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, was proud to sponsor and participate in the 2018 Bert Blain Memorial Heart Walk in Janesville, WI. Held on August 26th, the walk supported the American Heart Association’s mission to reduce disability and death caused by cardiovascular disease and stroke.
This is the second year SHINE has participated in the local Heart Walk, which is one of the largest in the nation and brings together hundreds in the Janesville community to improve heart health in Wisconsin. In 2017, SHINE raised more than double its fundraising goal, and this year is proud to have exceeded its goal for the second year in a row, raising $4,333.
“Once again, our SHINE employees, friends and family members stepped up to support the Heart Walk. As a start-up company and member of this community, SHINE is extremely proud to support this longtime Janesville event,” said Cheryl Peterson, Community and Employee Engagement Manager at SHINE. Ms. Peterson lead the SHINE team, 21 of whom participated in the walk. SHINE’s team currently ranks fourth in the Top Companies and Top Teams categories for fundraising.
SHINE understands that its business is enriched by the community it calls home and that everyone has a responsibility to give back. SHINE prioritizes opportunities for community engagement that complement its mission, including those that help eradicate heart disease and cancer.
This year marked the 26thanniversary of the Bert Blain Memorial Heart Walk. As of today, the Heart Walk has raised over $196,000, and final donations are still being collected.
Molybdenum-99 (Mo-99) is a radioisotope that decays into the diagnostic imaging agent technetium‑99m (Tc-99m). Tc-99m is used in more than 40 million medical imaging procedures each year, primarily in stress tests to diagnose heart disease and bone scans to stage cancer. SHINE was founded to deploy a safe, cost-effective and environmentally friendly technology to produce medical isotopes, including Mo‑99.
Based in Janesville, Wisconsin, SHINE deploys its safe, cost-effective and environmentally friendly fusion technology in a stepwise approach. Its systems are used to inspect industrial components in aerospace, defense, energy and other sectors. SHINE’s proprietary medical isotope production processes create non-carrier-added lutetium-177 and are expected to create molybdenum-99. In the future, SHINE plans to scale its fusion technology to help solve one of energy’s toughest hurdles by recycling nuclear waste. Through a purpose-driven and phased approach, SHINE aims to generate fusion power to deliver clean, abundant energy that could transform life on Earth. Want to learn more about SHINE? Follow us on social media @shinefusion and sign up for our email newsletter to follow us on our journey!
Media Contact: info@shinefusion.com
